Therapeutics Related News

Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform

GERMANTOWN, Md., and GAITHERSBURG, Md., Jan. 24, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that it has entered into [...]

By | January 24th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

RoosterBio Inc. Unites with Manufacturing Innovation Institutes, Joining Manufacturing USA Network

FREDERICK, MARYLAND (PRWEB) JANUARY 18, 2017 - Announced in December 2016, RoosterBio is now part of two new federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of Commerce Penny Pritzker has announced the award of a new National Institute [...]

By | January 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research

Cambridge, UK, 16 January 2017: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or the “Company”), the world leader in the application of gene editing technologies, today announces that it has broadened its gene editing capabilities through the amendment of a [...]

By | January 17th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

iGEM Startup PvP Biologics Closes a $35 Million Agreement with Pharmaceutical Company Takeda

Barely two months ago, synbio company PvP Biologics, spun out of Washington University. Last week, the company closed a $35 million deal with medical company Takeda to cover phase 1 clinical trials of KumaMax, a new engineered protein capable of [...]

By | January 11th, 2017|BioPharma & Healthcare, News, Therapeutics|

ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens

BOSTON and GERMANTOWN, Md., Jan. 10, 2017 /PRNewswire/ -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, and Intrexon Corporation (NYSE:XON), a leader in the engineering and industrialization of biology to improve the quality of life and health [...]

By | January 10th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Mount Tam Biotechnologies, Inc., and Isomerase Therapeutics Announce Expansion of Their Collaboration to Discover and Develop Novel Rapalogs

NOVATO, CA - (January 9, 2017) - Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM) is pleased to announce that Mount Tam and Cambridge, UK-based Isomerase Therapeutics Ltd (“Isomerase”) have agreed to expand their research collaboration for the discovery and [...]

By | January 10th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|